In 1988, a cardiovascular prevention program which combined an individual and a population-based strategy was launched within primary health-care in Sollentuna, a municipality in Stockholm County. The aim of this study was to investigate time trends in the incidence of and mortality from acute myocardial infarction and all-cause mortality in Sollentuna compared with the rest of Stockholm County during a period of two decades following the implementation of a cardiovascular prevention program.The average population in Sollentuna was 56,589 (49% men) and in Stockholm County (Sollentuna included) 1,795,504 (49% men) during the study period of 1987–2010. Cases of hospitalized acute myocardial infarction and death were obtained for the populatio...
BACKGROUND: We analyzed temporal trends in the incidence of myocardial infarction and ischemic strok...
AIMS: In western countries out-of-hospital ischaemic heart disease (IHD) deaths account for approxim...
The development of new evidence based diagnostic methods, drugs, interventions and medical devices i...
In 1988, a cardiovascular prevention program which combined an individual and a population-based str...
Background In 1988, a cardiovascular prevention program which combined an individual and a popula-ti...
In Stockholm county, a rapid decline in mortality from acute myocardial infarction (AMI) was observe...
Background: Cardiovascular disease (CVD) is the main cause of morbidity and mortality in Sweden. Thi...
Objective Due to the burden of coronary heart disease (CHD), the monitoring of CHD trends is require...
In this study, the geographical variation of the mortality rate in mid-Sweden was studied. Data on m...
Abstract Background Cardiovascular disease (CVD) is the main cause of morbidity and mortality in Swe...
Background: We analyzed temporal trends in the incidence of myocardial infarction and ischemic strok...
The aim of the present study was to evaluate the trends in attack rate, incidence, recurrence and 28...
OBJECTIVE: Due to the burden of coronary heart disease (CHD), the monitoring of CHD trends is requir...
Background: We analyzed temporal trends in the incidence of myocardial infarction and ischemic strok...
Background—Case fatality associated with a first coronary event is often underestimated when only th...
BACKGROUND: We analyzed temporal trends in the incidence of myocardial infarction and ischemic strok...
AIMS: In western countries out-of-hospital ischaemic heart disease (IHD) deaths account for approxim...
The development of new evidence based diagnostic methods, drugs, interventions and medical devices i...
In 1988, a cardiovascular prevention program which combined an individual and a population-based str...
Background In 1988, a cardiovascular prevention program which combined an individual and a popula-ti...
In Stockholm county, a rapid decline in mortality from acute myocardial infarction (AMI) was observe...
Background: Cardiovascular disease (CVD) is the main cause of morbidity and mortality in Sweden. Thi...
Objective Due to the burden of coronary heart disease (CHD), the monitoring of CHD trends is require...
In this study, the geographical variation of the mortality rate in mid-Sweden was studied. Data on m...
Abstract Background Cardiovascular disease (CVD) is the main cause of morbidity and mortality in Swe...
Background: We analyzed temporal trends in the incidence of myocardial infarction and ischemic strok...
The aim of the present study was to evaluate the trends in attack rate, incidence, recurrence and 28...
OBJECTIVE: Due to the burden of coronary heart disease (CHD), the monitoring of CHD trends is requir...
Background: We analyzed temporal trends in the incidence of myocardial infarction and ischemic strok...
Background—Case fatality associated with a first coronary event is often underestimated when only th...
BACKGROUND: We analyzed temporal trends in the incidence of myocardial infarction and ischemic strok...
AIMS: In western countries out-of-hospital ischaemic heart disease (IHD) deaths account for approxim...
The development of new evidence based diagnostic methods, drugs, interventions and medical devices i...